Economic impact and clinical profile of the secondary progressive multiple sclerosis (SPMS) patient: the DISCOVER study

被引：0

作者：

Oreja-Guevara, C. ^{[1
]}

Rio, J. ^{[2
]}

Ara Callizo, J. R. ^{[3
]}

Hernandez Perez, M. A. ^{[4
]}

Gracia Gil, J. ^{[5
]}

Alonso Torres, A. M. ^{[6
]}

Pilo de la Fuente, B. ^{[7
]}

Ramio-Torrenta, L. ^{[8
]}

Eichau Madueno, S. ^{[9
]}

Gascon Gimenez, F. ^{[10
]}

Casanova Estruch, B. ^{[11
]}

Martinez Yelamos, S. ^{[12
]}

Aguado Valcarcel, M. ^{[13
]}

Martinez Gines, M. ^{[14
]}

El Berdei Montero, Y. ^{[15
]}

Lopez Real, A. M. ^{[16
]}

Gonzalez Quintanilla, V. ^{[17
]}

Lopez de Silanes, C. ^{[18
]}

Martinez Rodriguez, J. E. ^{[19
]}

Costa-Frossard Franca, L. ^{[20
]}

Garces Redondo, M. ^{[21
]}

Labiano Fontcuberta, A. ^{[22
]}

Castellanos Pinedo, F. ^{[23
]}

Garcia Merino, J. A. ^{[24
]}

Munoz Fernandez, C. ^{[25
]}

Castillo Trivino, T. ^{[26
]}

Meca-Lallana, V. ^{[27
]}

Pena Martinez, J. ^{[28
]}

Rodriguez Antiguedad, A. ^{[29
]}

Prieto Gonzalez, J. M. ^{[30
]}

Aguera Morales, E. ^{[31
]}

Perez Molina, I. ^{[32
]}

Solar Sanchez, M. ^{[33
]}

Herrera Varo, N. ^{[34
]}

Meca-Lallana, J. E. ^{[35
]}

机构：

[1] Hosp Univ Clin San Carlos, Madrid, Spain

[2] Hosp Univ Vall dHebron, CEMCAT, Barcelona, Spain

[3] Hosp Univ Miguel Servet, Zaragoza, Spain

[4] Hosp Univ Nuestra Senora Candelaria, Santa Cruz De Tenerife, Spain

[5] Complejo Hosp Univ Albacete, Albacete, Spain

[6] Hosp Reg Univ Carlos Haya, Malaga, Spain

[7] Hosp Univ Getafe, Madrid, Spain

[8] Hosp Univ Girona Dr Josep Trueta, Girona, Spain

[9] Hosp Univ Virgen Macarena, Seville, Spain

[10] Hosp Clin Valencia, Valencia, Spain

[11] Hosp Univ & Politecn La Fe, Valencia, Spain

[12] Hosp Univ Bellvitge, Lhospitalet De Llobregat, Spain

[13] Hosp Alvaro Cunqueiro, Vigo, Spain

[14] Hosp Gregorio Maranon, Madrid, Spain

[15] Hosp Univ Salamanca, Salamanca, Spain

[16] Complexo Hosp Univ A Coruna, La Coruna, Spain

[17] Hosp Univ Marques Valdecilla, Cantabria, Spain

[18] Hosp Univ Torrejon, Madrid, Spain

[19] Hosp del Mar, Barcelona, Spain

[20] Hosp Univ Ramon y Cajal, Madrid, Spain

[21] Hosp Clin Univ Lozano Blesa, Zaragoza, Spain

[22] Hosp Univ 12 Octubre, Madrid, Spain

[23] Hosp Virgen Puerto Plasencia, Caceres, Spain

[24] Hosp Univ Puerta Hierro, Madrid, Spain

[25] Hosp Univ Torrecardenas, Almeria, Spain

[26] Hosp Univ Donostia, San Sebastian, Spain

[27] Hosp Univ La Princesa, Madrid, Spain

[28] Hosp Univ San Agustin, Asturias, Spain

[29] Hosp Univ Cruces, Baracaldo, Spain

[30] Hosp Clin Univ Santiago, Santiago De Compostela, Spain

[31] Hosp Univ Reina Sofia, Cordoba, Spain

[32] Hosp Virgen Salud, Toledo, Spain

[33] Hosp Univ Cabuenes, Gijon, Spain

[34] Hosp Univ Burgos, Burgos, Spain

[35] Hosp Clin Univ Virgen Arrixaca, Neurol Dept, CSUR Multiple Sclerosis & Clin Neuroimmunol Unit, IMIB Arrixaca, Murcia, Spain

来源：

MULTIPLE SCLEROSIS JOURNAL | 2021年 / 27卷 / 2_SUPPL期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P274

引用

页码：306 / 307

页数：2

共 50 条

[21] A clinical and laboratory study evaluating the profile of cytokine levels in relapsing remitting and secondary progressive multiple sclerosis
Pasquali, Livia
Lucchesi, Cinzia
Pecori, Chiara
Metelli, Maria Rita
Pellegrini, Silvia
Iudice, Alfonso
Bonuccelli, Ubaldo
JOURNAL OF NEUROIMMUNOLOGY, 2015, 278 : 53 - 59
[22] Diagnosing 'transition' to secondary progressive multiple sclerosis (SPMS): A step-by-step approach for clinicians
Hamdy, Eman
Talaat, Farouk
Ramadan, Ismail
Marouf, Hazem
Hamdy, Mohamed Mohamed
Sadallah, Horeya
El-Ashmawy, Ghada Abdel Hadi
Elsalamawy, Doaa
Said, Sameh Mahmoud
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 60
[23] Validation of the Scoring Algorithm for a Novel Integrative Secondary Progressive Multiple Sclerosis (SPMS) Screening Tool
Ziemssen, Tjalf
Meier, Daniela Piani
Bennett, Bryan
Johnson, Chloe
Tinsley, Katie
Trigg, Andrew
Dahlke, Frank
Tomic, Davorka
Tolley, Chloe
Freedman, Mark S.
NEUROLOGY, 2019, 92 (15)
[24] ASCEND Study of Natalizumab Efficacy on Disability in Patients with Secondary Progressive Multiple Sclerosis (SPMS): Baseline Demographics and Disease Characteristics
Mikol, Daniel
Freedman, Mark S.
Goldman, Myla D.
Hartung, Hans-Peter
Havrdova, Eva
Jeffery, Douglas
Kapoor, Raj
Miller, Aaron
Sellebjerg, Finn
Lee, Sophia
Chen, Yun
Cadavid, Diego
Ticho, Barry
ANNALS OF NEUROLOGY, 2013, 74 : S59 - S60
[25] Brainstem glioblastoma in a patient with secondary progressive multiple sclerosis
Vittorio Mantero
Roberto Balgera
Graziella Bianchi
Giorgio Rossi
Andrea Rigamonti
Anna Fiumani
Andrea Salmaggi
Neurological Sciences, 2015, 36 : 1733 - 1735
[26] Brainstem glioblastoma in a patient with secondary progressive multiple sclerosis
Mantero, Vittorio
Balgera, Roberto
Bianchi, Graziella
Rossi, Giorgio
Rigamonti, Andrea
Fiumani, Anna
Salmaggi, Andrea
NEUROLOGICAL SCIENCES, 2015, 36 (09) : 1733 - 1735
[27] Siponimod (BAF312) for the treatment of secondary progressive multiple sclerosis (SPMS): baseline characteristics of the EXPAND study population
Kappos, L.
Bar-Or, A.
Cree, B.
Fox, R.
Giovannoni, G.
Gold, R.
Vermersch, P.
Bhasin, P.
Arnould, S.
Sidorenko, T.
Wallstroem, E.
MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 317 - 318
[28] Effect of Siponimod on Cognition in Patients with Secondary Progressive Multiple Sclerosis (SPMS): Phase 3 EXPAND Study Subgroup Analysis
Benedict, Ralph
Fox, Robert
Tomic, Davorka
Cree, Bruce
Vermersch, Patrick
Giovannoni, Gavin
Bar-Or, Amit
Gold, Ralf
Ritter, Shannon
Karlsson, Goeril
Wolf, Christian
Kappos, Ludwig
NEUROLOGY, 2019, 92 (15)
[29] Cognitive and MRI profile in primary and secondary progressive multiple sclerosis
Mistri, D.
Cacciaguerra, L.
Valsasina, P.
Pagani, E.
Filippi, M.
Rocca, M. A.
MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 156 - 156
[30] Understanding the economic burden of secondary progressive multiple sclerosis in Portugal
Jose Sa, M.
Kobelt, G.
EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 933 - 933

← 1 2 3 4 5 →